|
Kester, a sector-focused private equity firm, has completed the first and final close of its fourth fund, Kester Capital Fund IV, at its hard cap of £425m. The four-month fundraise was materially oversubscribed, resulting in a single close driven by strong demand from both existing and new institutional investors. Fund IV marks a significant increase […]
The post Kester concludes first and final close of Fund IV at £425m hard cap appeared first on AltAssets Private Equity News.
|
|
Price are falling sharply for Medicare beneficiaries prescribed Novo Nordisk's GLP-1 drugs like Ozempic in 2027.
|
|
